Significant movement in price has been observed in Gaudium IVF and Women Health Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Gaudium IVF and Women Health Limited has submitted their response.
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
BSE and NSE wrote to Gaudium IVF asking for clarification on significant movement in the company's share price. In response, the company confirmed it has disclosed all material events and information to the exchanges as required under SEBI Listing Regulations (Regulation 30). The company stated there is no undisclosed price sensitive information or any impending corporate actions that could explain the price movement. The increase or decrease in share price was attributed to market forces. The company also reaffirmed its commitment to continued prompt disclosure of all material events under SEBI regulations.
The clarification is reassuring for shareholders as it confirms no undisclosed material information exists that could impact the stock. This is a routine compliance response, suggesting the price movement was market-driven rather than due to company-specific developments.